From Start-Up to Industrial Laboratory!

The Synprosis Story With its motto of "creative peptide design", Synprosis has rapidly gone from start-up to industrial-scale laboratory, to the point that, in July 2010, it swapped its 1600 sq. ft. offices in Château-Gombert for 27,000 sq. ft. premises at the Actipôle St-Charles in Fuveau! This exceptional growth is due to the choices made by a company that, as its CEO Jean-Pierre Salles points out, has from the beginning specialized in the manufacturing of synthetic peptides for therapeutic use, mainly for use in vaccines. If the choice of direction was considered risky then, today it seems an obvious one …